Print Page     Close Window     

SEC Filings

6-K
AC IMMUNE SA filed this Form 6-K on 08/09/2017
Entire Document
 
 

 

   For the Six Months
Ended June 30,
   
   2017  2016  Change
   (in CHF thousands, unaudited)
Operating expenses    2,045    1,689    356 
Salaries and related costs(1)    2,489    1,061    1,428 
Total general and administrative expenses    4,534    2,750    1,784 

 

(1)Includes share-based compensation

 

Related-Party Transactions

 

Related parties comprise of the Board of Directors and the Executive Management.

 

   For the Three Months
Ended June 30,
   
   2017  2016  Change
   (in CHF thousands, unaudited)
Short-term employee benefits (1)    772    523    249 
Post-employment benefits    34    39    (5)
Share-based compensation    92    15    77 
Total    898    577    321 

 

   For the Six Months
Ended June 30,
   
   2017  2016  Change
   (in CHF thousands, unaudited)
Short-term employee benefits (1)    1,244    984    260 
Post-employment benefits    71    77    (6)
Share-based compensation    92    30    62 
Total    1,407    1,091    316 

 

(1)The three and six months ended June 30, 2016 short-term employee benefits were revised to conform with current period presentation. Short-term employee benefits comprise of salaries, bonus, social security and expense allowances.

 

The Company granted 113,993 options to its new Chief Financial Officer, Joerg Hornstein, in April 2017. These represented all options granted as of and for the three and six months ended June 30, 2017 and 2016, respectively, to the Directors and Executive Management of the Company.

 

For the six months ended June 30, 2017, the Company granted 4,023 Restricted Shares as part of a Restricted Share Award to one of our Directors in accordance with our 2016 Stock Option and Incentive Plan.

 

4 


© AC Immune 2015